SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

From $200 million valuation to insolvency: Insurtech startup Sproutt heading for bankruptcy

April 2024 in Israeli tech funding: Over $1 billion in 20 deals

Remepy raises $10 million Seed round to bring first hybrid drug to market

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

2

Cyber startup Oasis secures $35 million Series A extension, doubles valuation

3

"Israel definitely needs to reconsider its strategy towards China"

4

Cyber startup Island doubles valuation to $3 billion in $175 million Series D

5

The Wiz effect? Cyber unicorns Aqua and Orca integrating platforms for joint customers

Analysts

2 stories about Analysts

קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich

Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price

Allergan to Sell Teva Shares to J.P. Morgan

14.11.17|Dror Reich and Lilach Baumer

Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018